Arkolith/Insider Trading/TCRX/Form 4

667, L.P.

DirectorTScan Therapeutics, Inc. (TCRX) · full profile →Form 4 · filed Apr 23, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 19, 2024Buy(P)826K$7.13$5.9M4.0M
Apr 19, 2024Buy(P)8.9M$7.13$63.1M43.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-046916) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML